Skip to main content
Log in

Differenze cliniche e laboratoristiche fra le ipofisiti primarie e le ipofisiti secondarie a immunoterapia

  • NOVITÀ IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Joshi MN, Whitelaw BC, Palomar MT et al. (2016) Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin Endocrinol 85:331–339

    Article  CAS  Google Scholar 

  2. Amereller F, Küppers A, Schilbach K et al. (2021) Clinical characteristics of primary hypophysitis – a single-centre series of 60 cases. Exp Clin Endocrinol Diabetes 129:234–240

    Article  CAS  Google Scholar 

  3. Cooper GS, Bynum ML, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33:197–207

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roberto Baldelli.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Colangelo, S., Franco, M., Zuppi, P. et al. Differenze cliniche e laboratoristiche fra le ipofisiti primarie e le ipofisiti secondarie a immunoterapia. L'Endocrinologo 23, 443–444 (2022). https://doi.org/10.1007/s40619-022-01141-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-022-01141-1

Navigation